Wright Medical Group N.V., a medical device company, designs, manufactures, markets, and sells upper and lower extremities, and biologics products in the United States, Europe, the Middle East, Africa, Canada, Asia, Australia, and Latin America. The company offers joint implants and bone fixation devices for the shoulder, elbow, wrist, hand, foot, and ankle; and biologics products that are used for supporting the treatment of damaged or diseased bones, tendons, and soft tissues, as well as to stimulate bone growth. It also provides sports medicines and other products to mechanically repair tissue-to-tissue or tissue-to-bone injuries, as well as other ancillary products. The company primarily offers its products to orthopedic, trauma, and podiatric surgeons. It markets and sells its products through direct sales representatives, independent sales agencies, direct sales offices, and distributors. The company was founded in 1999 and is headquartered in Amsterdam, the Netherlands.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
Phone31-20-521-4777
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$836.19 million
Profitability
Miscellaneous
Employees2,894
Next Earnings Date8/14/2019 (Estimated)
OptionableOptionable
Wright Medical Group (NASDAQ:WMGI) Frequently Asked Questions
What is Wright Medical Group's stock symbol?
Wright Medical Group trades on the NASDAQ under the ticker symbol "WMGI."
How often does Wright Medical Group pay dividends? What is the dividend yield for Wright Medical Group?
Wright Medical Group declared a dividend on Tuesday, December 11th. Investors of record on Wednesday, December 5th will be paid a dividend of $1.50 per share on Monday, December 10th. The ex-dividend date is Wednesday, December 12th. View Wright Medical Group's Dividend History.
How were Wright Medical Group's earnings last quarter?
Wright Medical Group NV (NASDAQ:WMGI) issued its earnings results on Tuesday, May, 7th. The medical device company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.02. The medical device company earned $230.13 million during the quarter, compared to analyst estimates of $226.10 million. Wright Medical Group had a negative net margin of 20.81% and a positive return on equity of 0.84%. Wright Medical Group's revenue for the quarter was up 15.9% compared to the same quarter last year. During the same period last year, the business posted ($0.01) earnings per share. View Wright Medical Group's Earnings History.
When is Wright Medical Group's next earnings date?
What guidance has Wright Medical Group issued on next quarter's earnings?
Wright Medical Group updated its FY19 earnings guidance on Tuesday, May, 7th. The company provided earnings per share (EPS) guidance of $0.17-0.25 for the period, compared to the Thomson Reuters consensus estimate of $0.21. The company issued revenue guidance of $954-966 million, compared to the consensus revenue estimate of $961.55 million.Wright Medical Group also updated its FY 2019 guidance to $0.17-0.25 EPS.
What price target have analysts set for WMGI?
14 Wall Street analysts have issued twelve-month price targets for Wright Medical Group's stock. Their predictions range from $31.00 to $40.00. On average, they anticipate Wright Medical Group's stock price to reach $34.9231 in the next year. This suggests a possible upside of 11.2% from the stock's current price. View Analyst Price Targets for Wright Medical Group.
What is the consensus analysts' recommendation for Wright Medical Group?
14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Wright Medical Group in the last year. There are currently 2 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Wright Medical Group.
What are Wall Street analysts saying about Wright Medical Group stock?
Here are some recent quotes from research analysts about Wright Medical Group stock:
- 1. Needham & Company LLC analysts commented, "WMGI’s 4Q18 revenue was consistent with its preannouncement while EBITDA and EPS beat consensus. For 2019, management provided revenue, EBITDA, and EPS guidance that all bracketed consensus. Organic revenue growth slowed to 10.1% (adjusted for selling days) from 14.4% in 3Q18 as strong US Lower Extremities growth was offset by slower US Upper Extremities growth (faced its toughest comp of the year). Given the improving Lower Extremities growth, Augment Injectable launch, and Cartiva acquisition, we have increased confidence that WMGI can exceed consensus in 2019 despite some likely moderation in its US Upper Extremities growth and we reiterate our Buy rating." (2/27/2019)
- 2. Cantor Fitzgerald analysts commented, "We reiterate our Overweight rating and a 12-month price target of $35 on shares of WMGI. We think WMGI is positioned to outperform expectations in 2018 with multiple drivers across each of its three primary segments (lower extremities, upper extremities, and biologics) to accelerate growth. We see WMGI’s valuation as attractive, as we expect innovative products to help WMGI to capitalize on the evolving market trends. Valuation Summary We base our $35 price target on a ~5.5x EV/Sales multiple on our 2019 sales estimate." (12/10/2018)
Has Wright Medical Group been receiving favorable news coverage?
Media stories about WMGI stock have trended somewhat negative recently, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Wright Medical Group earned a media sentiment score of -1.6 on InfoTrie's scale. They also assigned media coverage about the medical device company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the near term.
Who are some of Wright Medical Group's key competitors?
Some companies that are related to Wright Medical Group include Steris (STE), DEMANT A S/ADR (WILYY), MSA Safety (MSA), Avanos Medical (AVNS), Inogen (INGN), Wound Management Technologies (WNDM), Establishment Labs (ESTA), RTI Surgical (RTIX), ConforMIS (CFMS), Invacare (IVC), Sientra (SIEN), Lakeland Industries (LAKE), COLLPLANT HOLDI/S (CLGN), Histogenics (HSGX) and NanoVibronix (NAOV).
What other stocks do shareholders of Wright Medical Group own?
Who are Wright Medical Group's key executives?
Wright Medical Group's management team includes the folowing people:
- Mr. Robert J. Palmisano, Pres, CEO & Exec. Director (Age 74)
- Mr. Lance A. Berry, Exec. VP, CFO & COO (Age 47)
- Mr. Andrew C. Morton, Sr. VP & Chief HR Officer (Age 53)
- Mr. Kevin D. Cordell, Exec. VP & Chief Global Commercial Officer (Age 53)
- Mr. Peter S. Cooke, Pres of emerging markets, Australia & Japan (Age 54)
Who are Wright Medical Group's major shareholders?
Wright Medical Group's stock is owned by many different of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (8.32%), Janus Henderson Group PLC (2.51%), Redmile Group LLC (2.28%), Macquarie Group Ltd. (1.91%), Loomis Sayles & Co. L P (1.41%) and Northern Trust Corp (1.25%). Company insiders that own Wright Medical Group stock include Andrew C Morton, David D Stevens, Elizabeth H Weatherman, Gregory Morrison, James Lightman, Jennifer S Walker, John L Miclot, Jonathan Wesley Porter, Julie Andrews, Kevin C Oboyle, Kevin D Cordell, Lance A Berry, Patrick Fisher, Peter Cooke, Richard F Wallman and Robert P Burrows III. View Institutional Ownership Trends for Wright Medical Group.
Which major investors are selling Wright Medical Group stock?
WMGI stock was sold by a variety of institutional investors in the last quarter, including Voya Investment Management LLC, Janus Henderson Group PLC, Penn Capital Management Co. Inc., Northern Trust Corp, Penn Capital Management Co. Inc., Macquarie Group Ltd., Peregrine Capital Management LLC and Elk Creek Partners LLC. Company insiders that have sold Wright Medical Group company stock in the last year include Andrew C Morton, David D Stevens, Elizabeth H Weatherman, James Lightman, Jennifer S Walker, John L Miclot, Julie Andrews, Kevin C Oboyle, Kevin D Cordell, Lance A Berry, Patrick Fisher, Peter Cooke and Robert P Burrows III. View Insider Buying and Selling for Wright Medical Group.
Which major investors are buying Wright Medical Group stock?
WMGI stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Eagle Asset Management Inc., Renaissance Technologies LLC, OppenheimerFunds Inc., Carillon Tower Advisers Inc., Redmile Group LLC, Dimensional Fund Advisors LP and Pier Capital LLC. View Insider Buying and Selling for Wright Medical Group.
How do I buy shares of Wright Medical Group?
Shares of WMGI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Wright Medical Group's stock price today?
One share of WMGI stock can currently be purchased for approximately $31.41.
How big of a company is Wright Medical Group?
Wright Medical Group has a market capitalization of $3.96 billion and generates $836.19 million in revenue each year. Wright Medical Group employs 2,894 workers across the globe.
What is Wright Medical Group's official website?
How can I contact Wright Medical Group?
Wright Medical Group's mailing address is PRINS BERNHARDPLEIN 200, AMSTERDAM P7, 1097 JB. The medical device company can be reached via phone at 31-20-521-4777 or via email at [email protected]
MarketBeat Community Rating for Wright Medical Group (NASDAQ WMGI)
MarketBeat's community ratings are surveys of what our community members think about Wright Medical Group and other stocks. Vote "Outperform" if you believe WMGI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WMGI will underperform the S&P 500 over the long term. You may vote once every thirty days.
